Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07017543Not ApplicableActive Not Recruiting

Dynamics of Psychotherapy and Treatment Outcomes

Role: lead

NCT06237348Not ApplicableCompleted

Simeox Therapy at Home Versus Standard of Care in NCFB Patients With CMH

Role: collaborator

NCT06242119Recruiting

Clinical Application of the J-PET Scanner Prototype

Role: collaborator

NCT06618846Completed

Impact of Bariatric and Metabolic Surgery on the Reduction of Premature Aging.

Role: lead

NCT06249802Phase 4Not Yet Recruiting

Beta-blockade in Unruptured Intracranial Aneurysm

Role: collaborator

NCT05575050Not ApplicableCompleted

Impact of Teeth Brushing in Ventilated COVID-19 Patients.

Role: lead

All 6 trials loaded